Peripheral blood mononuclear cells (PBMCs) of CML patients showed increased frequencies of BDCA1+CD14+ cells when compared to PBMCs of healthy controls (p < 0.05; Figure 1). This evidence concerns the gene CD1C and chronic myelogenous leukemia, BCR-ABL1 positive.